Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine vs ropivacaine for anesthesia and early walking after tibia fracture surgery
IRCT20191104045328N42Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Oct 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in tibia fracture comparing Bupivacaine arm with Ropivacaine arm (2 arms). Primary endpoints: Quality of anesthesia and Early postoperative walking. Started Oct 2025; status: completed.
02
Drugs
bupivacaineropivacaine
03
Conditions
tibia fracture
Beyond the preview
Go deeper on IRCT20191104045328N42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191104045328N42.